Duke Debates: Gastrointestinal Malignancies (2.23.19)

December 6, 2018
By: Julie Poucher Harbin, Writer, DCI

This year's Duke Cancer Institute "Duke Debates: Controversies in the Management of Gastrointestinal Malignancies" will be held on Feb. 23, 2019 at the Umstead Hotel and Spa in Cary, North Carolina. 



7:30 a.m. Registration/Breakfast

8:00 a.m. Welcome

8:05 a.m. Key Note: Development of Personalized Treatments in Colorectal Cancer
Scott Kopetz, MD, PhD, FACP
Associate Professor, UT MD Anderson

9:00 a.m. DEBATE: Total Upfront vs. Sandwich Treatment in Early Stage Rectal Cancer

10:00 a.m. BREAK

10:20 a.m. DEBATE: Colon Cancer Stage II/III: 3 Months vs. 6 Months of Treatment?

11:20 a.m. DEBATE: Is There an Optimal Therapy for Early Stage Resectable Pancreatic Cancer?

12:20 p.m. LUNCH

1:20 p.m. What Does the Data Tell Us About Immunotherapy in Hepatocellular Cancer?

2:00 p.m. DEBATE: Metastatic Hepatocellular Cancer: To Resect or to Ablate?

3:00 p.m. BREAK 

3:20 p.m. DEBATE: Immunotherapy in Metastatic Gastric Cancer

4:20 p.m. Conclusion/Wrap-up